Approval · Notice of Compliance 32429 · 2023
VIAGRA: Notice of Compliance 32429
Issued December 28, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32429
- Date
- December 28, 2023
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Migrate the Product Monograph to the 2020 format. Addition of a new dosage form. Changes to manufacturing process.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIAGRA | Not yet assigned | — |
| VIAGRA | 02544172 | Marketed |
Medicinal ingredients
- SILDENAFIL CITRATE 25 MG per TAB
- SILDENAFIL CITRATE 50 MG per TAB
- SILDENAFIL CITRATE 100 MG per TAB